Descriptor English: | Atrazine | ||||
Descriptor Spanish: |
Atrazina
| ||||
Descriptor Portuguese: | Atrazina | ||||
Descriptor French: | Atrazine | ||||
Entry term(s): |
Gesamprim |
||||
Tree number(s): |
D03.383.931.247 |
||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D001280 | ||||
Scope note: | A selective triazine herbicide. Inhalation hazard is low and there are no apparent skin manifestations or other toxicity in humans. Acutely poisoned sheep and cattle may show muscular spasms, fasciculations, stiff gait, increased respiratory rates, adrenal degeneration, and congestion of the lungs, liver, and kidneys. (From The Merck Index, 11th ed) |
||||
Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||
Pharm Action: |
Herbicides |
||||
Registry Number: | QJA9M5H4IM | ||||
CAS Type 1 Name: | 1,3,5-Triazine-2,4-diamine, 6-chloro-N-ethyl-N'-(1-methylethyl)- | ||||
Previous Indexing: |
Herbicides (1966-1971) Triazines (1966-1971) |
||||
Public MeSH Note: | 74 |
||||
History Note: | 74(72) |
||||
DeCS ID: | 1286 | ||||
Unique ID: | D001280 | ||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||
Date Established: | 1974/01/01 | ||||
Date of Entry: | 1999/01/01 | ||||
Revision Date: | 2016/05/27 |
-
-
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds
|
Atrazine
- Preferred
Gesamprim
- Narrower
Concept UI |
M0001925 |
Scope note | A selective triazine herbicide. Inhalation hazard is low and there are no apparent skin manifestations or other toxicity in humans. Acutely poisoned sheep and cattle may show muscular spasms, fasciculations, stiff gait, increased respiratory rates, adrenal degeneration, and congestion of the lungs, liver, and kidneys. (From The Merck Index, 11th ed) |
Preferred term | Atrazine |
Concept UI |
M0353435 |
Preferred term | Gesamprim |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey